Getting to Breakthroughs Faster with Mass Quantities of Synthetic DNA

Posted by Nat Connors on 8/11/16 10:03 AM
In this video, Patrick Boyle, Head of Design at Ginkgo Bioworks, discusses how mass quantities of synthetic DNA speed his design-build-test cycles and how long-length DNA constructs open up design possibilities in synthetic biology research.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

SynBio Conversations: Sajith  Wickramasekara, Benchling (Part 2)

Posted by Nat Connors on 8/9/16 9:57 AM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part two of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

SynBio Conversations: Sajith Wickramasekara, Benchling (Part 1)

Posted by Nat Connors on 8/4/16 3:30 PM

As part of our continuing synthetic biology conversations series, we spoke with Saji Wickramasekara, Founder and CEO of Benchling, a San Francisco-based company working to make life science research faster and more collaborative. The following is part one of our two-part conversation with Saji.

Read More

Topics: Synthetic Biology, DNA Design, Benchling

The Power of DNA Synthesis: A Video

Posted by Nat Connors on 7/6/16 3:51 PM

A few weeks back, we announced that we'd signed a partnership with Ginkgo Bioworks to deliver 300 million base pairs of DNA through 2017. This unprecedented deal has been thought-provoking in many ways, and we’ve had some great questions arise from the synbio community and beyond. What will Ginkgo do with 300 megabases of content? How can Gen9 manufacture all that DNA? What could I do with pathway-length constructs like the ones Ginkgo uses?

We sat down with leaders at Ginkgo and Gen9 to learn more about what the partnership means for the future of synthetic biology.

Read More

Topics: Synthetic Biology, Gene Synthesis, Clonal, DNA Synthesis, DNA Design

300 Million Base Pairs and The Impact on The Synthetic Biology Industry

Posted by Kevin Munnelly on 6/8/16 2:30 PM

Earlier today, we announced some exciting news for the field of synthetic biology. We’re teaming up with Ginkgo Bioworks to supply 300 million base pairs of synthetic DNA between now and the end of 2017.  In this unprecedented deal, we will provide Ginkgo with massive quantities of pathway-length DNA constructs for use in their organism engineering platform.

Read More

Topics: Synthetic Biology

Top 5 Features for DNA Design at Gen9

Posted by Jeremy Brendle on 6/2/16 3:00 PM
As a technical support specialist here at Gen9, I work with scientists every day to help them get the DNA they need for the results they want. I am constantly amazed at the variety of projects that researchers are pursuing all over the world.  To enable all of this research our team and our collaborators at Benchling have worked hard to provide a fantastic tool for access to custom DNA synthesis on a massive scale.  Gen9’s online design portal is an awesome space to design the DNA that powers research, for bigger and better experiments. Check out some of my favorite portal features :
Read More

Topics: DNA Design

Why the Next Generation of our BioFab® Technology Changes the Game in Gene Synthesis

Posted by Andrew Bond on 4/1/16 3:40 PM

Last week, we announced the next generation of our BioFab® technology, an advancement that enables us to manufacture mass quantities of high quality, long-length, clonal DNA at prices as low as 3 cents per base pair. These game-changing economics will open doors for industrial users as they utilize megabase quantities of DNA on their journey towards new product discovery.

Read More

Topics: Synthetic Biology, Gene Synthesis, Multiplex, DNA Synthesis

Gen9ers Series: Brian Schneider

Posted by Nat Connors on 3/31/16 10:05 AM
Each month, we'll introduce you to a member of the extraordinary Gen9 team, or our Gen9ers (as we affectionately refer to our community). Today, you'll meet Brian Schneider, Director of Strategic Accounts for the Eastern United States. Brian joined the Gen9 team in August of 2015.
Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis

SynBio Conversations: Dr. Stephen Chambers, CEO of SynbiCITE

Posted by Nat Connors on 3/3/16 12:30 PM
We caught up with Dr. Stephen Chambers, CEO of SynbiCITE, to discuss our recent partnership, learn more about the UK synthetic biology landscape, and talk about the future of the field.
Read More

Topics: Synthetic Biology, DNA Synthesis, SynbiCITE

The Power of Partnership  - Gen9 and SynbiCITE

Posted by Kevin Munnelly on 2/24/16 1:51 PM

Last week, we announced a partnership with SynbiCITE, the UK’s national center for the commercialization of synthetic biology. We’re thrilled to join forces with a visionary organization that is on the forefront of synthetic biology innovation and is opening doors for the next generation of breakthroughs in biology. 

Read More

Topics: Synthetic Biology, Gene Synthesis, DNA Synthesis, SynbiCITE

Start the Conversation

Gen9's Blog

Founded by pioneering scientists in fabrication, genetics, and bio-engineering, the Gen9 vision is one of democratizing synthetic biology. Our goal is to enable broad adoption of powerful synthetic biology techniques by providing custom DNA constructs of the highest possible quality. 

This blog will serve as a platform to:

  • Educate our readers about the goings-on at Gen9
  • Keep our followers up-to-date with service updates and product enhancements
  • Share our views on current events in the Synthetic Biology world

Subscribe to Email Updates